1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Neurodegenerative Disease Market Size Growth Rate by Type (2020-2025)
1.3.2 NMDA
1.3.3 SSRIs
1.3.4 Dopamine Inhibitors
1.4 Market Segment by Application
1.4.1 Global Neurodegenerative Disease Market Share by Application (2020-2025)
1.4.2 Parkinson\'s Disease
1.4.3 Huntington Disease
1.4.4 Amyotrophic Lateral Sclerosis
1.4.5 Alzheimer\'s Disease
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Market Size
2.1.1 Global Neurodegenerative Disease Revenue 2015-2025
2.1.2 Global Neurodegenerative Disease Sales 2015-2025
2.2 Neurodegenerative Disease Growth Rate by Regions
2.2.1 Global Neurodegenerative Disease Sales by Regions 2015-2019
2.2.2 Global Neurodegenerative Disease Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Neurodegenerative Disease Sales by Manufacturers
3.1.1 Neurodegenerative Disease Sales by Manufacturers 2015-2019
3.1.2 Neurodegenerative Disease Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Neurodegenerative Disease Revenue by Manufacturers (2015-2019)
3.2.2 Neurodegenerative Disease Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI)
3.3 Neurodegenerative Disease Price by Manufacturers
3.4 Key Manufacturers Neurodegenerative Disease Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Neurodegenerative Disease Market
3.6 Key Manufacturers Neurodegenerative Disease Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 NMDA Sales and Revenue (2015-2019)
4.1.2 SSRIs Sales and Revenue (2015-2019)
4.1.3 Dopamine Inhibitors Sales and Revenue (2015-2019)
4.2 Global Neurodegenerative Disease Sales Market Share by Type
4.3 Global Neurodegenerative Disease Revenue Market Share by Type
4.4 Neurodegenerative Disease Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Neurodegenerative Disease Sales by Application
6 United States
6.1 United States Neurodegenerative Disease Breakdown Data by Company
6.2 United States Neurodegenerative Disease Breakdown Data by Type
6.3 United States Neurodegenerative Disease Breakdown Data by Application
7 European Union
7.1 European Union Neurodegenerative Disease Breakdown Data by Company
7.2 European Union Neurodegenerative Disease Breakdown Data by Type
7.3 European Union Neurodegenerative Disease Breakdown Data by Application
8 China
8.1 China Neurodegenerative Disease Breakdown Data by Company
8.2 China Neurodegenerative Disease Breakdown Data by Type
8.3 China Neurodegenerative Disease Breakdown Data by Application
9 Rest of World
9.1 Rest of World Neurodegenerative Disease Breakdown Data by Company
9.2 Rest of World Neurodegenerative Disease Breakdown Data by Type
9.3 Rest of World Neurodegenerative Disease Breakdown Data by Application
9.4 Rest of World Neurodegenerative Disease Breakdown Data by Countries
9.4.1 Rest of World Neurodegenerative Disease Sales by Countries
9.4.2 Rest of World Neurodegenerative Disease Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.1.4 Neurodegenerative Disease Product Introduction
10.1.5 Novartis Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.2.4 Neurodegenerative Disease Product Introduction
10.2.5 Pfizer Recent Development
10.3 Merck Serono
10.3.1 Merck Serono Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.3.4 Neurodegenerative Disease Product Introduction
10.3.5 Merck Serono Recent Development
10.4 Biogen Idec
10.4.1 Biogen Idec Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.4.4 Neurodegenerative Disease Product Introduction
10.4.5 Biogen Idec Recent Development
10.5 TEVA
10.5.1 TEVA Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.5.4 Neurodegenerative Disease Product Introduction
10.5.5 TEVA Recent Development
10.6 UCB
10.6.1 UCB Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.6.4 Neurodegenerative Disease Product Introduction
10.6.5 UCB Recent Development
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.7.4 Neurodegenerative Disease Product Introduction
10.7.5 Boehringer Ingelheim Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.8.4 Neurodegenerative Disease Product Introduction
10.8.5 Sanofi Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Neurodegenerative Disease
10.9.4 Neurodegenerative Disease Product Introduction
10.9.5 GlaxoSmithKline Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Neurodegenerative Disease Sales Channels
11.2.2 Neurodegenerative Disease Distributors
11.3 Neurodegenerative Disease Customers
12 Market Forecast
12.1 Global Neurodegenerative Disease Sales and Revenue Forecast 2020-2025
12.2 Global Neurodegenerative Disease Sales Forecast by Type
12.3 Global Neurodegenerative Disease Sales Forecast by Application
12.4 Neurodegenerative Disease Forecast by Regions
12.4.1 Global Neurodegenerative Disease Sales Forecast by Regions 2020-2025
12.4.2 Global Neurodegenerative Disease Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
